Alopecia

Exton, Pennsylvania, July 11, 2023 (GLOBE NEWSWIRE) -- In June 2022, Eli Lilly and Incyte’s Olumiant became the first and only approved advanced systemic treatment for adults with severe…

The FDA approved the Janus kinase (JAK) inhibitor ritlecitinib (Litfulo) for…

“I was fixed with the same challenges that many patients have; hearing, ‘We don’t know what causes it and there’s not much we can do except inject steroids into your scalp and hope for the…

What caused three women in their 20s and 30s to have significant diffuse hair loss? That's…

NEW ORLEANS -- Patients with severe alopecia areata had dramatic hair regrowth at 6 months with an investigational Janus kinase…

Patients with alopecia areata (AA) had rates of anxiety and depression two to three times…

Receding hairline (hair loss) is no more only a man's problem, say experts.Losing your hair might cause you to lose confidence and cause emotional stress. There are several reasons why you…

Pune, India, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Fortune Business Insights has published latest forecast for alopecia treatment market in their report titled, “Alopecia Treatment Market…

The medication, made by Eli Lilly, is called baricitinib, part of the Janus kinase (JAK) inhibitor class. Two other JAK inhibitors for the condition (one from Pfizer and another from Concert…

University of California, Irvine-led researchers have discovered that a signaling molecule called SCUBE3 potently stimulates hair growth and may offer a therapeutic treatment for…